Topic Editors
Bone-Related Diseases: From Molecular Mechanisms to Therapy Development—2nd Edition
Topic Information
Dear Colleagues,
The prevalence and incidence of bone-related diseases (fractures, osteoarthritis, osteoporosis, bone tumors, etc.) are increasing with the current developments in society, especially in the aging population. These diseases often result in pain and disability and incapacitate people in their daily life, which imposes a considerable global socioeconomic burden. Therefore, it is imperative to explore the biomarkers and molecular mechanisms for early diagnosis and targeted treatment of bone-related diseases. With the rise in systematic biology and bioinformatics, more analytical techniques, including single-cell sequencing (scSeq), cytometry by time-of-flight (CyTOF), and bulk RNA-Seq, have been applied to achieve a deeper understanding of the mechanisms of these diseases, such as their genomics, proteomics, metabolomics, and transcriptomics. Particularly, molecular mechanisms of bone-related diseases could be identified from the analysis of genes, proteins, metabolites, etc. In this Topic, we welcome original research or review articles relating to new insights into pathogenesis, potential biomarkers, and recent advances in the study of bone-related diseases. The submission of original articles, reviews, mini-reviews, and commentaries is welcomed. Topics of interest include but are not limited to the following:
- Mechanism of action research, including molecular and cellular mechanisms and key signaling pathways in bone-related diseases.
- Novel therapeutic strategies in the treatment of bone-related diseases.
- Biomarker studies in bone tumors and other bone-related diseases.
- Drug development, including PD, PK, toxicity, and efficacy evaluation, for osteoarthritis, osteoporosis, and other bone-related diseases.
- Clinical trials, including on osteoarthritis, osteoporosis, and bone tumors.
Dr. Xin Dong
Dr. Xiao Wang
Topic Editors
Keywords
- bone-related diseases
- osteoporosis
- osteoarthritis
- multi-omics analysis
- biomarkers
- early diagnosis
- molecular mechanisms
- clinical trials
Participating Journals
| Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
|---|---|---|---|---|---|---|
Biomolecules
|
4.8 | 9.2 | 2011 | 19.4 Days | CHF 2700 | Submit |
International Journal of Molecular Sciences
|
4.9 | 9.0 | 2000 | 20.5 Days | CHF 2900 | Submit |
Journal of Clinical Medicine
|
2.9 | 5.2 | 2012 | 17.7 Days | CHF 2600 | Submit |
Biomedicines
|
3.9 | 6.8 | 2013 | 17 Days | CHF 2600 | Submit |
Osteology
|
- | - | 2021 | 22.3 Days | CHF 1000 | Submit |
Cells
|
5.2 | 10.5 | 2012 | 16 Days | CHF 2700 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
